A Vutrisiran Sodium (25mg 0.5ml/syringe) 3 syringes,B Elapegademase (Genetical Recombination) (2.4mg 1.5ml/vial) 23 vials,C Durvalumab (Genetical Recombination) (500mg 10ml/vial) 105 vials,D Pembrolizumab (Genetical Recombination) (100mg 4... (Япония - Тендер #62347519) | ||
| ||
Для перевода текста тендера на нужный язык воспользуйтесь приложением: | ||
Страна: Япония (другие тендеры и закупки Япония) Организатор тендера: Government Procurement Japan Номер конкурса: 62347519 Дата публикации: 17-03-2025 Источник тендера: Государственные закупки Японии |
||
This procurement is covered by the WTO Agreement on Government Procurement, Japan-EU Economic Partnership Agreement or Japan-UK Comprehensive Economic Partnership Agreement.
Publishing date | Mar 17, 2025 |
---|---|
Type of notice | Notice of Procurement (Goods & Services) |
Procurement entity | National University Corporation - Hokkaido |
Classification | 0004 Medical & Pharmaceutical Products |
Summay of notice |
⑴ Official in charge of disbursement of the procuring entity : HOUKIN Kiyohiro, President, The National University Corporation Hokkaido University ⑵ Classification of the products to be procured : 4 ⑶ Nature and quantity of the products to be purchased : A Vutrisiran Sodium (25mg 0.5ml/syringe) 3 syringes B Elapegademase (Genetical Recombination) (2.4mg 1.5ml/vial) 23 vials C Durvalumab (Genetical Recombination) (500mg 10ml/vial) 105 vials D Pembrolizumab (Genetical Recombination) (100mg 4ml/vial) 234 vials E Tisagenlecleucel 1 set F Axicabtagene Ciloleucel 1 set G Lisocabtagene Maraleucel 1 set H Idecabtagene Vicleucel 2 sets I Onasemnogene Abeparvovec 1 set ⑷ Delivery period : From 1 June, 2025 through 31 May, 2026 ⑸ Delivery place : Hokkaido University Hospital ⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall : A The following shall apply for each of the subjects listed in 5⑶ above. A~C have the Grade A, Grade B, Grade C or Grade D qualification during fiscal 2025 in the Hokkaido area in Sales of products for participating in tenders by Single qualification for every ministry and agency, or in tenders by Hokkaido University, D~I have the Grade A, Grade B, or Grade C qualification during fiscal 2025 in the Hokkaido area in Sales of products for participating in tenders by Single qualification for every ministry and agency, or in tenders by Hokkaido University, B The following shall apply for each of the subjects listed in 5⑶ above. A~D prove to have obtained the wholesale distribution license for selling pharmaceuticals in accordance with The Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices, E~I prove to have obtained the license for selling regenerative medicine products in accordance with The Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices, C prove to have the ability to deliver the products, required by this notice, on the date and to the place specified by the President, D not be currently under a suspension of business order as instructed by the President, The National University Corporation Hokkaido University. ⑺ Time limit of tender : 17 : 00 7 May, 2025 ⑻ Contact point for the notice : TOBIOKA Naoki, Medicine Section, Financial Division, Hokkaido University Hospital, Kita 14 Nishi 5 Kita-ku Sapporo-shi 060-8648 Japan, TEL 011-706-7405 ⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents. |